Phraction Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Sell |
29,966
-198
| -0.7% | -$80.3K | 3.89% | 7 |
|
|
2025
Q1 | $15M | Buy |
30,164
+2,037
| +7% | +$1.01M | 5.03% | 3 |
|
|
2024
Q4 | $14.6M | Buy |
28,127
+527
| +2% | +$274K | 5.13% | 4 |
|
|
2024
Q3 | $17.1M | Buy |
27,600
+395
| +1% | +$244K | 6.04% | 3 |
|
|
2024
Q2 | $15M | Buy |
27,205
+172
| +0.6% | +$95.1K | 5.5% | 4 |
|
|
2024
Q1 | $15.7M | Sell |
27,033
-430
| -2% | -$250K | 6.05% | 3 |
|
|
2023
Q4 | $14.6M | Buy |
27,463
+6,784
| +33% | +$3.6M | 6.02% | 4 |
|
|
2023
Q3 | $10.5M | Buy |
20,679
+2,089
| +11% | +$1.06M | 4.94% | 7 |
|
|
2023
Q2 | $9.7M | Buy |
18,590
+5,255
| +39% | +$2.74M | 4.79% | 7 |
|
|
2023
Q1 | $7.69M | Buy |
13,335
+1,918
| +17% | +$1.11M | 4.41% | 8 |
|
|
2022
Q4 | $6.29M | Buy |
11,417
+100
| +0.9% | +$55.1K | 4.13% | 11 |
|
|
2022
Q3 | $5.74M | Buy |
11,317
+282
| +3% | +$143K | 4.33% | 8 |
|
|
2022
Q2 | $6M | Buy |
11,035
+950
| +9% | +$516K | 3.94% | 7 |
|
|
2022
Q1 | $5.96M | Buy |
10,085
+510
| +5% | +$301K | 3.43% | 7 |
|
|
2021
Q4 | $6.39M | Buy |
+9,575
| New | +$6.39M | 3.87% | 5 |
|